Item 7.01 Regulation FD Disclosure.

On October 15, 2021, Tonix Pharmaceuticals Holding Corp. (the "Company") issued a press release announcing a ribbon-cutting ceremony for its infectious disease research and development center in Frederick, Maryland. A copy of the press release is furnished as Exhibit 99.01 hereto and incorporated herein by reference.

The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.01 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the United States Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the United States Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.






(d)  Exhibit
       No.                                 Description.
      99.01     Press release of the Company, dated October 15, 2021
       104      Cover Page Interactive Data File (embedded within the Inline XBRL
                document).

© Edgar Online, source Glimpses